INSP
Inspire Medical Systems, Inc.
Price Chart
Latest Quote
$43.15
-0.05 (-0.12%)
Current Price
| Previous Close | $43.20 |
| Open | $43.78 |
| Day High | $44.45 |
| Day Low | $43.15 |
| Volume | 175,876 |
Stock Information
| Shares Outstanding | 28.81M |
| Total Debt | $29.55M |
| Cash Equivalents | $283.83M |
| Revenue | $915.25M |
| Net Income | $131.14M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.24B |
| P/E Ratio | 9.81 |
| EPS (TTM) | $4.40 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $990.45M |
| Sales | $915.25M |
| Income | $131.14M |
| Book/sh | $27.51 |
| Cash/sh | $9.85 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 4.35 |
| Current Ratio | 6.34 |
| Debt/Eq | 3.73 |
Returns & Margins
| ROA | 3.91% |
| ROE | 18.37% |
| Gross Margin | 85.78% |
| Operating Margin | -0.55% |
| Profit Margin | 14.33% |
Ownership
| Insider Ownership | 1.14% |
| Institutional Ownership | 122.11% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 33.37 |
| P/S | 1.36 |
| P/B | 1.57 |
Analyst Data
| Recommendation | hold |
| Target Price | $50.92 |
Technical Indicators
| SMA20 | $41.85 |
| SMA50 | $46.24 |
| SMA200 | $72.32 |
| RSI | 55.17 |
| ATR | 1.9794 |
| Shares Float | 26.95M |
| Short Float | 16.81% |
| Short Ratio | 2.57 |
| Volatility | 0.73 |
| Rel Volume | 0.20 |
Performance History
| Week | +4.93% |
| Month | +2.76% |
| Quarter | -16.07% |
| 6 Months | -55.94% |
| YTD | -53.24% |
| Year | -67.45% |
| 3 Years | -86.22% |
| 5 Years | -77.25% |
| 10 Years | +72.73% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $43.15 | 175,876 |
| 2026-06-24 | $43.20 | 804,100 |
| 2026-06-23 | $41.75 | 793,000 |
| 2026-06-22 | $41.35 | 700,100 |
| 2026-06-18 | $42.61 | 1,386,500 |
| 2026-06-17 | $41.12 | 559,900 |
| 2026-06-16 | $41.39 | 646,200 |
| 2026-06-15 | $41.13 | 1,041,700 |
| 2026-06-12 | $42.70 | 1,047,500 |
| 2026-06-11 | $42.44 | 971,100 |
| 2026-06-10 | $42.28 | 764,900 |
| 2026-06-09 | $42.21 | 604,600 |
| 2026-06-08 | $41.94 | 732,700 |
| 2026-06-05 | $41.19 | 725,000 |
| 2026-06-04 | $42.19 | 839,700 |
| 2026-06-03 | $40.44 | 1,141,000 |
| 2026-06-02 | $40.58 | 967,400 |
| 2026-06-01 | $40.84 | 1,635,700 |
| 2026-05-29 | $41.36 | 1,131,000 |
| 2026-05-28 | $43.07 | 922,100 |
| 2026-05-27 | $42.22 | 1,067,200 |
| 2026-05-26 | $41.99 | 1,461,500 |
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
đ° Latest News
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down
StockStory âĸ 2026-06-23T08:40:46Z
INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026
Zacks âĸ 2026-06-22T14:30:00Z
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool âĸ 2026-06-11T16:09:27Z
3 Stocks Under $50 We Steer Clear Of
StockStory âĸ 2026-06-04T23:33:30Z
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?
Zacks âĸ 2026-06-03T15:30:08Z
Is Inspire Medical Systems (INSP) Reset Creating A Potential Opportunity For Investors Now
Simply Wall St. âĸ 2026-06-03T15:08:30Z
1 Profitable Stock Worth Your Attention and 2 We Find Risky
StockStory âĸ 2026-06-03T13:59:33Z
Spotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & Supplies - Specialty Stocks In Q1
StockStory âĸ 2026-05-29T17:12:38Z
What Does Stifel Think About Inspire Medical (INSP) After a Guidance Cut That Surprised Wall Street?
Insider Monkey âĸ 2026-05-27T21:56:35Z
Analyst warns Inspire Medical has a problem lasting into 2028
TheStreet âĸ 2026-05-27T18:17:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $133,225,000 | $122,986,000 | $96,576,000 | $66,115,000 |
| Cost Of Revenue | $133,225,000 | $122,986,000 | $96,576,000 | $66,115,000 |
| Total Revenue | $911,981,000 | $802,804,000 | $624,799,000 | $407,856,000 |
| Operating Revenue | $911,981,000 | $802,804,000 | $624,799,000 | $407,856,000 |
| Expenses | ||||
| Interest Expense | $137,000 | $22,000 | $0 | $1,677,000 |
| Total Expenses | $861,027,000 | $766,721,000 | $665,070,000 | $455,448,000 |
| Other Income Expense | $-2,656,000 | $-855,000 | $-195,000 | $-49,000 |
| Other Non Operating Income Expenses | $-2,656,000 | $-855,000 | $-195,000 | $-49,000 |
| Net Non Operating Interest Income Expense | $17,399,000 | $23,225,000 | $20,560,000 | $3,373,000 |
| Interest Expense Non Operating | $137,000 | $22,000 | $0 | $1,677,000 |
| Operating Expense | $727,802,000 | $643,735,000 | $568,494,000 | $389,333,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Net Interest Income | $17,399,000 | $23,225,000 | $20,560,000 | $3,373,000 |
| Interest Income | $17,536,000 | $23,247,000 | $20,560,000 | $5,050,000 |
| Normalized Income | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Net Income From Continuing And Discontinued Operation | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Total Operating Income As Reported | $50,954,000 | $36,083,000 | $-40,271,000 | $-47,592,000 |
| Net Income Common Stockholders | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Net Income | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Net Income Including Noncontrolling Interests | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Net Income Continuous Operations | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Pretax Income | $65,697,000 | $58,453,000 | $-19,906,000 | $-44,268,000 |
| Interest Income Non Operating | $17,536,000 | $23,247,000 | $20,560,000 | $5,050,000 |
| Operating Income | $50,954,000 | $36,083,000 | $-40,271,000 | $-47,592,000 |
| Gross Profit | $778,756,000 | $679,818,000 | $528,223,000 | $341,741,000 |
| Per Share | ||||
| Diluted EPS | $4.89 | $1.75 | $-0.72 | $-1.60 |
| Basic EPS | $4.95 | $1.80 | $-0.72 | $-1.60 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $79,791,000 | $65,025,000 | $-17,060,000 | $-40,733,000 |
| Reconciled Depreciation | $13,957,000 | $6,550,000 | $2,846,000 | $1,858,000 |
| EBITDA (Bullshit earnings) | $79,791,000 | $65,025,000 | $-17,060,000 | $-40,733,000 |
| EBIT | $65,834,000 | $58,475,000 | $-19,906,000 | $-42,591,000 |
| Diluted Average Shares | $29,757,036 | $29,763,395 | $29,302,154 | $28,071,748 |
| Basic Average Shares | $29,368,892 | $29,763,395 | $29,302,154 | $28,071,748 |
| Diluted NI Availto Com Stockholders | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Tax Provision | $-79,725,000 | $4,944,000 | $1,247,000 | $613,000 |
| Research And Development | $103,165,000 | $114,128,000 | $116,536,000 | $68,645,000 |
| Selling General And Administration | $624,637,000 | $529,607,000 | $451,958,000 | $320,688,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $781,160,000 | $689,695,000 | $572,514,000 | $496,008,000 |
| Total Assets | $907,317,000 | $808,383,000 | $676,811,000 | $564,876,000 |
| Total Non Current Assets | $323,665,000 | $177,577,000 | $83,072,000 | $34,844,000 |
| Other Non Current Assets | $17,264,000 | $11,330,000 | $11,278,000 | $10,715,000 |
| Non Current Deferred Assets | $88,667,000 | $13,000 | - | - |
| Non Current Deferred Taxes Assets | $88,667,000 | $13,000 | - | - |
| Investmentin Financial Assets | $96,330,000 | $70,995,000 | $9,143,000 | $0 |
| Current Assets | $583,652,000 | $630,806,000 | $593,739,000 | $530,032,000 |
| Other Current Assets | $10,399,000 | $12,074,000 | $9,595,000 | $5,505,000 |
| Inventory | $145,293,000 | $80,118,000 | $33,885,000 | $11,886,000 |
| Receivables | $119,692,000 | $93,068,000 | $89,884,000 | $61,228,000 |
| Accounts Receivable | $119,692,000 | $93,068,000 | $89,884,000 | $61,228,000 |
| Allowance For Doubtful Accounts Receivable | $-1,080,000 | $-880,000 | $-1,648,000 | $-36,000 |
| Gross Accounts Receivable | $120,772,000 | $93,948,000 | $91,532,000 | $61,264,000 |
| Cash Cash Equivalents And Short Term Investments | $308,268,000 | $445,546,000 | $460,375,000 | $451,413,000 |
| Cash And Cash Equivalents | $104,813,000 | $150,150,000 | $185,537,000 | $441,592,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $32,155,000 | $31,793,000 | $24,846,000 | $8,872,000 |
| Long Term Debt And Capital Lease Obligation | $29,998,000 | $30,039,000 | $24,846,000 | $7,536,000 |
| Current Debt And Capital Lease Obligation | $2,157,000 | $1,754,000 | - | $1,336,000 |
| Long Term Debt | - | - | - | - |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $126,157,000 | $118,688,000 | $104,297,000 | $68,868,000 |
| Total Non Current Liabilities Net Minority Interest | $30,102,000 | $30,187,000 | $26,192,000 | $7,682,000 |
| Other Non Current Liabilities | $104,000 | $148,000 | $1,346,000 | $146,000 |
| Current Liabilities | $96,055,000 | $88,501,000 | $78,105,000 | $61,186,000 |
| Payables And Accrued Expenses | $93,898,000 | $86,747,000 | $78,105,000 | $59,850,000 |
| Payables | $39,017,000 | $40,299,000 | $39,416,000 | $26,847,000 |
| Total Tax Payable | $2,452,000 | $1,612,000 | $577,000 | - |
| Income Tax Payable | $2,452,000 | $1,612,000 | $577,000 | - |
| Accounts Payable | $36,565,000 | $38,687,000 | $38,839,000 | $26,847,000 |
| Interest Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $781,160,000 | $689,695,000 | $572,514,000 | $496,008,000 |
| Total Equity Gross Minority Interest | $781,160,000 | $689,695,000 | $572,514,000 | $496,008,000 |
| Stockholders Equity | $781,160,000 | $689,695,000 | $572,514,000 | $496,008,000 |
| Gains Losses Not Affecting Retained Earnings | $464,000 | $536,000 | $800,000 | $-86,000 |
| Other Equity Adjustments | $464,000 | $536,000 | $800,000 | $-86,000 |
| Retained Earnings | $-146,492,000 | $-291,914,000 | $-345,423,000 | $-324,270,000 |
| Other | ||||
| Ordinary Shares Number | $28,579,015 | $29,740,176 | $29,560,464 | $29,008,368 |
| Share Issued | $28,579,015 | $29,740,176 | $29,560,464 | $29,008,368 |
| Tangible Book Value | $781,160,000 | $689,695,000 | $572,514,000 | $496,008,000 |
| Invested Capital | $781,160,000 | $689,695,000 | $572,514,000 | $496,008,000 |
| Working Capital | $487,597,000 | $542,305,000 | $515,634,000 | $468,846,000 |
| Capital Lease Obligations | $32,155,000 | $31,793,000 | $24,846,000 | $8,872,000 |
| Total Capitalization | $781,160,000 | $689,695,000 | $572,514,000 | $496,008,000 |
| Additional Paid In Capital | $927,159,000 | $981,043,000 | $917,107,000 | $820,335,000 |
| Capital Stock | $29,000 | $30,000 | $30,000 | $29,000 |
| Common Stock | $29,000 | $30,000 | $30,000 | $29,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $29,998,000 | $30,039,000 | $24,846,000 | $7,536,000 |
| Current Capital Lease Obligation | $2,157,000 | $1,754,000 | $0 | $1,336,000 |
| Current Accrued Expenses | $54,881,000 | $46,448,000 | $38,689,000 | $33,003,000 |
| Investments And Advances | $96,330,000 | $70,995,000 | $9,143,000 | $0 |
| Available For Sale Securities | $96,330,000 | $70,995,000 | $9,143,000 | - |
| Net PPE | $121,404,000 | $95,239,000 | $62,651,000 | $24,129,000 |
| Accumulated Depreciation | $-25,650,000 | $-13,758,000 | $-7,271,000 | $-4,910,000 |
| Gross PPE | $147,054,000 | $108,997,000 | $69,922,000 | $29,039,000 |
| Leases | $11,768,000 | $10,057,000 | $2,356,000 | $2,064,000 |
| Construction In Progress | $24,380,000 | $24,975,000 | $33,211,000 | $11,857,000 |
| Other Properties | $54,206,000 | $34,098,000 | $9,418,000 | $6,509,000 |
| Machinery Furniture Equipment | $33,168,000 | $16,553,000 | $2,270,000 | $1,729,000 |
| Buildings And Improvements | $23,532,000 | $23,314,000 | $22,667,000 | $6,880,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $112,359,000 | $57,688,000 | $27,770,000 | $6,241,000 |
| Work In Process | $13,837,000 | $0 | - | - |
| Raw Materials | $19,097,000 | $22,430,000 | $6,115,000 | $5,645,000 |
| Other Short Term Investments | $203,455,000 | $295,396,000 | $274,838,000 | $9,821,000 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $78,477,000 | $91,123,000 | $1,024,000 | $2,473,000 |
| Operating Activities | ||||
| Operating Cash Flow | $116,976,000 | $130,246,000 | $24,653,000 | $11,569,000 |
| Cash Flow From Continuing Operating Activities | $116,976,000 | $130,246,000 | $24,653,000 | $11,569,000 |
| Investing Activities | ||||
| Capital Expenditure | $-38,499,000 | $-39,123,000 | $-23,629,000 | $-9,096,000 |
| Investing Cash Flow | $21,446,000 | $-113,122,000 | $-294,822,000 | $-19,596,000 |
| Cash Flow From Continuing Investing Activities | $21,446,000 | $-113,122,000 | $-294,822,000 | $-19,596,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-175,019,000 | $-75,000,000 | $0 | $0 |
| Financing Cash Flow | $-183,449,000 | $-52,393,000 | $13,950,000 | $235,077,000 |
| Cash Flow From Continuing Financing Activities | $-183,449,000 | $-52,393,000 | $13,950,000 | $235,077,000 |
| Net Other Financing Charges | $-23,044,000 | $-5,165,000 | $-17,158,000 | $-43,000 |
| Net Common Stock Issuance | $-175,019,000 | $-75,000,000 | $0 | $243,801,000 |
| Issuance Of Capital Stock | - | $0 | $0 | $243,801,000 |
| Common Stock Issuance | - | $0 | $0 | $243,801,000 |
| Other | ||||
| Interest Paid Supplemental Data | $137,000 | $22,000 | $0 | $2,321,000 |
| End Cash Position | $104,813,000 | $150,150,000 | $185,537,000 | $441,592,000 |
| Beginning Cash Position | $150,150,000 | $185,537,000 | $441,592,000 | $214,467,000 |
| Effect Of Exchange Rate Changes | $-310,000 | $-118,000 | $164,000 | $75,000 |
| Changes In Cash | $-45,027,000 | $-35,269,000 | $-256,219,000 | $227,050,000 |
| Proceeds From Stock Option Exercised | $14,614,000 | $27,772,000 | $31,108,000 | $15,819,000 |
| Common Stock Payments | $-175,019,000 | $-75,000,000 | $0 | $0 |
| Net Investment Purchase And Sale | $59,945,000 | $-73,999,000 | $-271,193,000 | $-10,500,000 |
| Sale Of Investment | $310,381,000 | $344,605,000 | $10,246,000 | $0 |
| Purchase Of Investment | $-250,436,000 | $-418,604,000 | $-281,439,000 | $-10,500,000 |
| Net PPE Purchase And Sale | $-38,499,000 | $-39,123,000 | $-23,629,000 | $-9,096,000 |
| Purchase Of PPE | $-38,499,000 | $-39,123,000 | $-23,629,000 | $-9,096,000 |
| Change In Working Capital | $-87,381,000 | $-37,710,000 | $-40,781,000 | $1,810,000 |
| Change In Payables And Accrued Expense | $2,376,000 | $13,469,000 | $16,194,000 | $26,297,000 |
| Change In Accrued Expense | $6,123,000 | $12,865,000 | $6,898,000 | $11,942,000 |
| Change In Payable | $-3,747,000 | $604,000 | $9,296,000 | $14,355,000 |
| Change In Account Payable | $-3,747,000 | $604,000 | $9,296,000 | $14,355,000 |
| Change In Prepaid Assets | $1,651,000 | $-2,344,000 | $-4,758,000 | $-2,815,000 |
| Change In Inventory | $-65,175,000 | $-46,233,000 | $-21,999,000 | $5,345,000 |
| Change In Receivables | $-26,233,000 | $-2,602,000 | $-30,218,000 | $-27,017,000 |
| Changes In Account Receivables | $-26,233,000 | $-2,602,000 | $-30,218,000 | $-27,017,000 |
| Other Non Cash Items | $2,111,000 | $1,517,000 | $2,128,000 | $879,000 |
| Stock Based Compensation | $130,259,000 | $116,007,000 | $82,470,000 | $51,970,000 |
| Provisionand Write Offof Assets | $200,000 | $-768,000 | $1,612,000 | $-63,000 |
| Asset Impairment Charge | $4,046,000 | $0 | $0 | - |
| Amortization Of Securities | $-2,889,000 | $-8,859,000 | $-2,469,000 | $-4,000 |
| Deferred Tax | $-88,749,000 | $0 | $0 | - |
| Deferred Income Tax | $-88,749,000 | $0 | $0 | - |
| Depreciation Amortization Depletion | $13,957,000 | $6,550,000 | $2,846,000 | $1,858,000 |
| Depreciation And Amortization | $13,957,000 | $6,550,000 | $2,846,000 | $1,858,000 |
| Net Income From Continuing Operations | $145,422,000 | $53,509,000 | $-21,153,000 | $-44,881,000 |
| Repayment Of Debt | - | $0 | $0 | $-24,500,000 |
| Net Issuance Payments Of Debt | - | $0 | $0 | $-24,500,000 |
| Net Long Term Debt Issuance | - | $0 | $0 | $-24,500,000 |
| Long Term Debt Payments | - | $0 | $0 | $-24,500,000 |
Fetched: 2026-06-20